- Omega Diagnostics said it had received its first purchase orders for an HIV desting kit.

Purchase orders for Visitect CD4 350 cut-off test came from distributors supplying into Indonesia, Moldova and Papua New Guinea.

As expected, the order quantities were low at this stage and reflected distributors' intentions to seed their private business-to-business market channels in the initial stages.

'Nevertheless, this is an endorsement of the company's ability to develop and then commercialise this product through the regulatory processes in international markets.'

'We expect to supply customers before the end of the current financial year.'

At 8:24am: [LON:ODX] Omega Diagnostics Group PLC share price was +0.25p at 13.5p

Story provided by